Company / Capital Expenditures
Alkermes plc Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$40.4M
FY2025
5-year range
$28.0M / $48.0M
FY2021-FY2025
Trend
+20.7%
vs FY2024
Sector context
#29 of 194
Health Care
What the data says
Alkermes plc's capital expenditures of $40M is higher than 85% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $28M in FY2021 to $91M in FY2019.
Based on SEC 10-K filings.
$40M in FY2025 with a 5-year CAGR of -0.9%. Top quartile in the Health Care sector.
Declined from $48M to $40M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
-65.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.9%, indicating a declining trend.
- In FY2025, capital expenditures increased 20.7% year-over-year.
- Ranks #29 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- Strong profit margin: 22.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.4M | +20.7% |
| FY2024 | $33.5M | -30.3% |
| FY2023 | $48.0M | +25.6% |
| FY2022 | $38.3M | +36.5% |
| FY2021 | $28.0M | -33.6% |
| FY2020 | $42.2M | -53.6% |
| FY2019 | $90.9M | +31.0% |
| FY2018 | $69.4M | +35.3% |
| FY2017 | $51.3M | +17.5% |
| FY2016 | $43.7M | +129.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026